These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3594682)

  • 1. A physiologically based pharmacokinetic model for biperiden in animals and its extrapolation to humans.
    Nakashima E; Yokogawa K; Ichimura F; Kurata K; Kido H; Yamaguchi N; Yamana T
    Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):718-25. PubMed ID: 3594682
    [No Abstract]   [Full Text] [Related]  

  • 2. Fundamental pharmacokinetic properties of biperiden: tissue distribution and elimination in rabbits.
    Yokogawa K; Nakashima E; Ichimura F; Yamana T
    J Pharmacobiodyn; 1986 Apr; 9(4):409-16. PubMed ID: 3735062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fasting on biperiden pharmacokinetics in the rat.
    Nakashima E; Yokogawa K; Ichimura F; Hashimoto T; Yamana T; Tsuji A
    J Pharm Sci; 1987 Jan; 76(1):10-3. PubMed ID: 3585715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes.
    Eltze M; Figala V
    Eur J Pharmacol; 1988 Dec; 158(1-2):11-9. PubMed ID: 3220113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fat tissue volume on the distribution kinetics of biperiden as a function of age in rats.
    Yokogawa K; Nakashima E; Ichimura F
    Drug Metab Dispos; 1990; 18(2):258-63. PubMed ID: 1971583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor occupancy by biperiden in living human brain.
    Sudo Y; Suhara T; Suzuki K; Okubo Y; Yoshikawa K; Uchida S; Sassa T; Okauchi T; Sasaki Y; Matsushita M
    Life Sci; 1999; 64(8):PL99-104. PubMed ID: 10069534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiparkinsonian drugs budipine and biperiden are use-dependent (uncompetitive) NMDA receptor antagonists.
    Jackisch R; Kruchen A; Sauermann W; Hertting G; Feuerstein TJ
    Eur J Pharmacol; 1994 Oct; 264(2):207-11. PubMed ID: 7851484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of lipophilicity and lysosomal accumulation on tissue distribution kinetics of basic drugs: a physiologically based pharmacokinetic model.
    Yokogawa K; Ishizaki J; Ohkuma S; Miyamoto K
    Methods Find Exp Clin Pharmacol; 2002 Mar; 24(2):81-93. PubMed ID: 12040887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous microdetermination of biperiden, haloperidol, and trihexyphenidyl in plasma and its application to pharmacokinetic analysis after concomitant intravenous administration of the drugs to rabbits.
    Yokogawa K; Nakashima E; Ichimura F; Yamana T
    Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4581-6. PubMed ID: 4092273
    [No Abstract]   [Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man.
    Tsuji A; Nishide K; Minami H; Nakashima E; Terasaki T; Yamana T
    Drug Metab Dispos; 1985; 13(6):729-39. PubMed ID: 2867880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 3H-pipethiaden after single oral and intravenous administration in rats.
    Lapka R; Franc Z; Smolik S
    Arzneimittelforschung; 1985; 35(2):486-8. PubMed ID: 4039570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative metabolism and disposition of penfluridol-3H in the rat, rabbit, dog, and man.
    Grindel JM; Migdalof BH; Cressman WA
    Drug Metab Dispos; 1979; 7(5):325-9. PubMed ID: 40775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biotransformation and pharmacokinetics of bamipine in rats. 2. Studies of the pharmacokinetics (1.)].
    Neidlein VR; Kleiser M
    Arzneimittelforschung; 1987 Feb; 37(2):174-7. PubMed ID: 2883979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transepithelial transport of biperiden hydrochloride in Caco-2 cell monolayers.
    Abalos IS; Rodríguez YI; Lozano V; Cereseto M; Mussini MV; Spinetto ME; Chiale C; Pesce G
    Environ Toxicol Pharmacol; 2012 Sep; 34(2):223-227. PubMed ID: 22554863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of physiological variations of piperidine levels in tissues by mass fragmentography.
    Miyata T; Okano Y; Murao K; Fukunaga K; Takahama K; Kasé Y
    Life Sci; 1979 Nov; 25(20):1731-8. PubMed ID: 575183
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and tissue distribution of the new gastrokinetic agent cisapride in rat, rabbit and dog.
    Michiels M; Monbaliu J; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1987 Oct; 37(10):1159-67. PubMed ID: 3435588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amnesic effects of the anticholinergic drugs, trihexyphenidyl and biperiden: differences in binding properties to the brain muscarinic receptor.
    Kimura Y; Ohue M; Kitaura T; Kihira K
    Brain Res; 1999 Jul; 834(1-2):6-12. PubMed ID: 10407088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and localization of serotonin2 (S2)-receptor-binding sites: effects of neuronal lesions.
    Leysen JE; Van Gompel P; Verwimp M; Niemegeers CJ
    Adv Biochem Psychopharmacol; 1983; 37():373-83. PubMed ID: 6356803
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism of antiparkinson drugs. An example of competitive hydroxylation].
    Stock B; Spiteller G
    Arzneimittelforschung; 1979; 29(4):610-5. PubMed ID: 582755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The acute toxicity of eserine, VX and paraoxon for the establishment of a mathematical model for extrapolation to humans].
    Leblic C; Coq HM; Le Moan G
    Arch Belg; 1984; Suppl():226-42. PubMed ID: 6535472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.